Cheema Research Incorporated

Mississauga, Ontario L5A 3V4

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Chronic Spontaneous Urticaria

Studies at this site

• Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria — Completed
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis — Stopped early